L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease.

scientific article

L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1445-5994.1974.TB03207.X
P698PubMed publication ID4278910

P2093author name stringGlasgow GL
Willoughby EW
Henley JW
P2860cites workFailure of vitamin B6 to reverse the L-dopa effect in patients on a dopa decarboxylase inhibitorQ41996129
Prevention or reversal of levodopa-induced cardiac arrhythmias by decarboxylase inhibitorsQ42230336
Parkinson's Disease: Activity of L-Dopa Decarboxylase in Discrete Brain RegionsQ43495374
Methyldopahydrazine as an adjunct to L-dopa therapy in parkinsonismQ48775284
Levodopa in Parkinsonism: Potentiation of Central Effects with a Peripheral InhibitorQ51107835
Idiopathic Parkinsonism Treated with an Extracerebral Decarboxylase Inhibitor in Combination with LevodopaQ55061662
P433issue4
P921main subjectmethyldopaQ412621
(S)-(−)-carbidopa monohydrateQ414225
Parkinson's diseaseQ11085
P304page(s)373-378
P577publication date1974-08-01
P1433published inAustralian and New Zealand journal of medicineQ27709236
P1476titleL-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease.
P478volume4

Reverse relations

cites work (P2860)
Q92455127Emerging Role of l-Dopa Decarboxylase in Flaviviridae Virus Infections
Q40575022Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism

Search more.